Madrigal Pharmaceuticals, Inc. (MDGL)

514.06 -42.16 (-7.58%) USD  |  NASDAQ  |  Jan 09, 16:00
517.00 +2.94 (+0.57%) After-Hours: 20:00
More

Madrigal Pharmaceuticals Net Common Equity Issued (Purchased) (Annual)

Net Common Equity Issued (Purchased) (Annual) Chart

View Net Common Equity Issued (Purchased) (Annual) for MDGL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Common Equity Issued (Purchased) (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Common Equity Issued (Purchased) (Annual) Range, Past 5 Years

View Net Common Equity Issued (Purchased) (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Common Equity Issued (Purchased) (Annual) Benchmarks

View Net Common Equity Issued (Purchased) (Annual) Benchmarks
Start Trial
Eli Lilly & Co. Upgrade
Amgen, Inc. Upgrade
Pfizer Inc. Upgrade
Crinetics Pharmaceuticals, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade